Papers
2
Total Citations
45
H-Index
2
About
Wim H. van Harten is a leading health services researcher whose work bridges surgical innovation and health economics, with a particular focus on prostate cancer care. His major contributions center on evaluating the real-world effectiveness and cost-efficiency of robot-assisted radical prostatectomy (RARP) compared to traditional laparoscopic approaches. In his landmark 2021 study, van Harten led a national retrospective cluster analysis in the Netherlands, demonstrating that RARP yields significantly improved long-term urinary functioning—a finding that has shaped clinical guidelines and surgical decision-making. Building on this, his 2022 cost-utility analysis quantified the economic value of these functional benefits, showing that while robot-assisted surgery carries higher upfront costs, the superior long-term outcomes may justify its use in select patient populations. With over 45 citations across his most-cited works, van Harten’s research is widely referenced by urologists, health policy makers, and health technology assessment agencies. His work exemplifies how rigorous outcomes research can inform value-based healthcare, ensuring that technological advances in surgery are matched by evidence of tangible patient benefit.
Research Focus
Key Achievements
Top Papers
- 1
- 2